Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
I consider wikipedia’s definitions linked below of these two side effects to be fairly comprehensive. My only edit would be the percentage of cancer survivors who are affected with nerve damage. Nerve damage, from chemo or radiation, isn’t yes or no.
The yes or no comes into play for one reason only. Yes, chemotherapy and radiation cause nerve damage. How much damage and how to heal that damage is the issue.
I believe that most all long-term cancer survivors live with some degree of nerve damage. Survivors may notice their handwriting slowly deteriorate. Or they may experience occasional tingling in the hands or feet. Nerve conduction and re-growth slow as a normal part of aging. The long-term cancer survivor can’t be sure what is normal aging of nerves vs. CIPN or RILP.
While the survivor may or may not call their nerve damage a formal name is beside the point.
What is my point then? My point is that CIPN/RIPN survivors can decide to heal their nerve damage based on the degree of pain or the degree of functional loss that they experience. In other words, like your
you can choose to take steps, undergo therapies shown to improve function. I am not saying that we will ever be as good, as functional as we were when we were young. I am saying that there are dozens of evidence-based, non-toxic, non-conventional therapies shown to heal your deficits.
Let me state at the outset that I don’t think cancer patients die from either CIPN or RILP. These two debilitating side effects are all about quality-of-life- QOL. The blog posts linked below document many challenges as well as therapies of living with these late stage side effects.
Benefit of chemotherapy? Benefit of Radiation?
When I write about my long-term side effects such as CIPN, RILP, Dysphagia, Xerostomia, CIC, DVT, Afib, Chemobrain and my ASCT, the issue is not about conventional cancer therapies- yes or no, but the over-treatment, the aggressive use of these toxic therapies in cancer care that are the issue.
My personal experience coupled with dozens of studies cite how conventional oncology could use a lower doses, could use less toxicity to manage their patients. Not only would the patients live longer, in my opinion anyway, those patients would live a much higher quality-of-life. Better, longer lives.
Integrative therapies to reduce the severity of CIPN and/or RILP-
The basic definition of integrative therapy, at least where cancer is concerned, is the idea that a non-toxic nutritional supplement could be combined with the toxic chemotherapy regimen enhancing the efficacy of the chemo while reducing the toxicity of that chemo regimen at the same time.
The same idea holds for radiation therapy. Research as shown the resveratrol, for example, protects tissue from the damaging effects of radiation.
If you are a cancer patient who is experiencing minor numbness or tingling in your hands or feet, one of three things may happen to you-
Conventional FDA approved SOC conventional oncology offers few if any solutions to serious CIPN/RILP. I have come to believe that real relief of this debilitating, painful long-term side effect lies in evidence-based, non-conventional therapies.
“Chronic pain is a major public health issue in the United States right now. And it’s the most common side effect of cancer treatment..”
“Chemotherapy-Induced Peripheral Neuropathy is often under-recognized and probably under-reported…”
“Nerve pain affects many people worldwide, and many now turn to cannabis for neuropathic pain relief. Here is a brief outline of neuropathic pain and a list of the best cannabis strains for nerve pain.”
“Melatonin as a potent antioxidant has shown appropriate immune regulatory properties that may ameliorate toxicity induced by radiation in various organs...”
“Chemotherapy-induced peripheral neuropathy (CIPN) may negatively influence multiple myeloma (MM) patients’ health-related quality of life.”